Kerry-Anne Rye obtained her PhD from The Flinders University of South Australia in 1986 and gained her postdoctoral training at The University of Illinois at Urbana-Champaign. Dr Rye then held positions at the Baker Institute in Melbourne and at the University of Adelaide before relocating to The Heart Research Institute in Sydney in 2003. She moved to the University of New South Wales in Sydney in 2013, where she is based in the School of Medical Sciences, Faculty of Medicine. Dr Rye’s early research career focussed on the regulation of HDL structure and remodelling by plasma factors such as cholesteryl ester transfer protein, phospholipid transfer protein, lecithin:cholesterol acytransferase and members of the triglyceride lipase gene family. Her current research is concerned with the anti-inflammatory and anti-diabetic functions of HDL. She has published over 200 peer-reviewed articles and invited reviews on these topics. Dr Rye serves on the Editorial Boards of Arteriosclerosis Thrombosis and Vascular Biology, The Journal of the American Heart Association and Circulation Research and is an Associate Editor of the Journal of Lipid Research. She is a member of the American Heart Association ATVB Council Leadership Committee, and runs a mentoring program for early career ATVB Council members. She also represents the ATVB Council as Chair of the American Heart Association Scientific Sessions Program Committee. Dr Rye is the recipient of the American Heart Association ATVB Council Distinguished Achievement Award for 2015.